Ronald A Kohanski

Title: The Innovative Contributions of Ronald A. Kohanski

Introduction

Ronald A. Kohanski is a notable inventor based in Fair Lawn, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of protein kinase inhibitors. His work has implications for anti-cancer therapies and biological tools in cell signaling.

Latest Patents

Kohanski holds a patent for bisubstrate inhibitors of kinases. This patent focuses on potent and selective inhibitors for the insulin receptor tyrosine kinase, which are based on a phosphoryl transfer mechanism involving a dissociative transition state. One of the synthesized inhibitors links ATPγS to a peptide substrate analog via a two-carbon spacer. This compound acts as a high-affinity competitive inhibitor against both nucleotide and peptide substrates, demonstrating a slow off-rate. A crystal structure of this inhibitor bound to the tyrosine kinase domain of the insulin receptor confirms the design features inspired by a dissociative transition state, revealing that the linker participates in the octahedral coordination of an active site magnesium ion.

Career Highlights

Throughout his career, Kohanski has worked at prestigious institutions such as the Icahn School of Medicine at Mount Sinai and Johns Hopkins University. His research has focused on the mechanisms of kinase inhibition and its applications in cancer treatment.

Collaborations

Kohanski has collaborated with esteemed colleagues, including Philip A. Cole and Keykavous Parang. These collaborations have further advanced the understanding of kinase inhibitors and their therapeutic potential.

Conclusion

Ronald A. Kohanski's innovative work in the field of protein kinase inhibitors has paved the way for new therapeutic strategies in cancer treatment. His contributions continue to influence research and development in biochemistry and pharmacology.